Green Planet Bio Engineering Co. Ltd.

Green Planet Bio Engineering Co. Ltd. (ticker: GPLB) is an OTC-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of GPLB's SEC filings surfaces 14 active risk signals, including 12 late-filing signals, and 2 auditor-change signals. GPLB reported no tagged revenue in revenue and -$36K for the period ending 2025-12-31, with operating cash flow of -$37K. Cash and equivalents stood at $0. Total assets of $0 are exceeded by total liabilities of $284K. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.